Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-κB signalling

Gut

Volumn 58, Issue 8, 2009, Pages 1078-1083

  Trynka, G ^a   Zhernakova, A ^b   Romanos, J ^a   Franke, L ^a,c   Hunt, K A ^c   Turner, G ^d   Bruinenberg, M ^a   Heap, G A ^c   Platteel, M ^a   Ryan, A W ^d   De Kovel, C ^b   Holmes, G K T ^e   Howdle, P D ^f   Walters, J R F ^g   Sanders, D S ^h   Mulder, C J J ⁱ   Mearin, M L ^j   Verbeek, W H M ⁱ   Trimble, V ^d   Stevens, F M ^k   Kelleher, D ^d   Barisani, D ^l   Bardella, M T ^m,n   McManus, R ^d   Van Heel, D A ^c   Wijmenga, C ^a,b   more..

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d TRINITY COLLEGE DUBLIN   (Ireland)

^e DERBYSHIRE ROYAL INFIRMARY   (United Kingdom)

^f ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^g HAMMERSMITH HOSPITAL   (United Kingdom)

^h ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

ⁱ VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^j LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^k NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^l UNIVERSITY OF MILANO BICOCCA   (Italy)

^m FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

ⁿ UNIVERSITY OF MILAN   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 3; RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR REL; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 3; UNCLASSIFIED DRUG;

ARTICLE; CELIAC DISEASE; CHROMOSOME 2P; CHROMOSOME 6Q; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC IDENTIFICATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SELECTION; GENETIC VARIABILITY; GENOTYPE; HERITABILITY; HLA SYSTEM; HUMAN; IRELAND; ITALY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RNA ANALYSIS; RNA ISOLATION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM;

CASE-CONTROL STUDIES; CELIAC DISEASE; FEMALE; GENES, REL; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LINKAGE DISEQUILIBRIUM; MALE; NF-KAPPA B; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; SIGNAL TRANSDUCTION;

EID: 66049120977     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.169052     Document Type: Article

References (26)

1. Hunt KA, Zhernakova A, Turner G, et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet 2008;40:395-402.
2. Zhernakova A, Alizadeh BZ, Bevova M, et al. Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases. Am J Hum Genet 2007;81:1284-8.
3. Zhernakova A, Festen EM, Franke L, et al. Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP. Am J Hum Genet 2008;82:1202-10.
4. Zhernakova A, van Diemen CC, Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 2009;10:43-55.
5. van Heel DA, Franke L, Hunt KA, et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet 2007;39:827-9.
6. Todd JA, Walker NM, Cooper JD, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007;39:857-64.
7. Consortium WTCC. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-78.
8. Romanos J. Six new celiac disease loci replicated in an Italian population confirm association to celiac disease. J Med Genet 2009;46;60-3.
9. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-75.
10. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
11. Heap GA, Trynka G, Jansen RC, et al. Complex nature of SNP genotype effects on gene expression in primary human leucocytes. BMC Med Genomics 2009;2:1.
12. Dixon AL, Liang L, Moffatt MF, et al. A genome-wide association study of global gene expression. Nat Genet 2007;39:1202-7.
13. Stranger BE, Nica AC, Forrest MS, et al. Population genomics of human gene expression. Nat Genet 2007;39:1217-24.
14. Plenge RM, Cotsapas C, Davies L, et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet 2007;39:1477-82.
15. Thomson W, Barton A, Ke X, et al. Rheumatoid arthritis association at 6q23. Nat Genet 2007;39:1431-3.
16. Graham RR, Cotsapas C, Davies L, et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet 2008;40:1059-61.
17. Musone SL, Taylor KE, Lu TT, et al. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet 2008;40:1062-4.
18. Sun SC. Deubiquitylation and regulation of the immune response. Nat Rev Immunol 2008;8:501-11.
19. Boone DL, Turer EE, Lee EG, et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 2004;5:1052-60.
20. Lee EG, Boone DL, Chai S, et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 2000;289:2350-4.
21. Turer EE, Tavares RM, Mortier E, et al. Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20. J Exp Med 2008;205:451-64.
22. Coornaert B, Carpentier I, Beyaert R. A20: Central gatekeeper in inflammation and immunity. J Biol Chem 2009;284:8217-21.
23. Xavier RJ, Rioux JD. Genome-wide association studies: a new window into immune-mediated diseases. Nat Rev Immunol 2008;8:631-43.
24. Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 2007;8:49-62.
25. Stene LC, Honeyman MC, Hoffenberg EJ, et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol 2006;101:2333-40.
26. Song XT, Evel-Kabler K, Shen L, et al. A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell-mediated suppression. Nat Med 2008;14:258-65.